Role of Taxanes in Advanced Prostate Cancer|
Docetaxel, as first-line therapy, and cabazitaxel, as second-line therapy, have demonstrated to increase the survival in castration-resistant prostate cancer. The results from last studies either on high-risk localized disease or on androgen-sensitive tumors demonstrate the increasing role of taxanes at earlier states of prostate cancer. [Clin Transl Oncol] Abstract
Visit our reviews page to see a complete list of reviews in the prostate cell research field.